US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Ophthalmology Market Research Reports & Industry Analysis

A portion of ophthalmology that resists change unlike some other specialties is the consumer reluctance to undertake a procedure that may have side effects associated with vision like refractive laser correction. Any side effects concerning eyes/vision is typically avoided as much as possible especially if there are other options.
Typically if the out-of pocket price for a life-enhancing procedure is within the budget of a consumer, the patient has a strong desire to get the procedure, and other factors are present that allow for it, the procedure is undertaken. In laser correction there has been skepticism which has diminished as more patients undertake the procedure with good results. While new ideas, breakthrough technologies, cost efficiencies, increased productivity,and new markets are the keys to growth and competitiveness, most people [work force; consumers; academics; politicians] are more confident in familiar environments. They will resist change unless their job, livelihood, or lifestyles are threatened.

This phenomenon is partly responsible for the trend toward closing solo and small group practices to join vision care networks. Though this experience exists more in general medical practices and some pecialties, ophthalmologists also face the threat of practitioners [osteopathic physicians, doctors of optometry] replacing eye MDs—an intrusion on their medical training, skills, and specialty. However increasing healthcare costs, and economic changes sometimes force shifts in the typical work pattern of healthcare providers. One example is a change that has happened in states across the U.S. allowing optometrists to diagnose and treat glaucoma.

RSS Feeds

Ophthalmology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
10/1/2014 | published by: CHI Insight Pharma Reports
... dry) and devling into Anti-VEGF therapies in chapter 2. Further providing substantial weight to this report, several companies were interviewed on their approach to targeting wet and dry AMD, thier strategies for seeking alternative therapeutic ...  |  read more...
USD 1,995
Global Ophthalmic Lasers Market 2014-2018
10/15/2014 | published by: TechNavio - Infiniti Research Ltd.
... macular degeneration, diabetic retinopathy, retinal disorders, and cataract and vision correction problems. These devices are highly accurate and affective as they allow patients to return home on the day of surgery, avoiding hospital stay or ...  |  read more...
USD 2,500
Manufacturing Opticians (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 210 largest Manufacturing Opticians (UK) companies. The Manufacturing Opticians (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019
9/23/2014 | published by: MarketsandMarkets
... at a CAGR of 9.6% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the ablation technologies market in 2014, the Asia-Pacific region is ...  |  read more...
USD 4,650
Uveitis - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
... Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Ophthalmics Partnering Terms & Agreements
8/1/2014 | published by: Current Partnering
... or development stage whereby the licensee obtains a right or an option right to license the licensors opthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report ...  |  read more...
USD 1,995
Glaucoma Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... by value •Deals listed by company A-Z, industry sector, stage of development, technology type Glaucoma Partnering 2009-2014 provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 695
Global Cytomegalovirus Retinitis Market : 2014-2018
8/13/2014 | published by: TechNavio - Infiniti Research Ltd.
... Roche Ltd., Gilead Sciences Inc., Hospira Inc. and Shire plc. Other Prominent Vendors in the market are: Auritec Pharmaceuticals, Chimerix Pharmaceuticals, Isis Pharmaceuticals, pSivida and Sanofi. Commenting on the report, an analyst from TechNavio’s team ...  |  read more...
USD 2,500
Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019)
9/1/2014 | published by: Daedal Research
... with a special focus on major categories- pharmaceuticals and devices. The report includes detailed information on market size and share by type of drugs in glaucoma treatment sector. It also discusses key growth drivers, challenges ...  |  read more...
USD 800
Dry Eye Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... deals •Top dry eye deals by value •Deals listed by company A-Z, industry sector, stage of development, technology type Dry Eye Partnering 2009-2014 provides understanding and access to the dry eye partnering deals and agreements ...  |  read more...
USD 695
Ophthalmics Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Glaucoma - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Age-related Macular Degeneration Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... age-related macular degeneration partnering deals •Top age-related macular degeneration deals by value •Deals listed by company A-Z, industry sector, stage of development, technology type Age-related Macular Degeneration Partnering 2009-2014 provides understanding and access to the ...  |  read more...
USD 695
Conjunctivitis Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... by value •Deals listed by company A-Z, industry sector, stage of development, technology type Conjunctivitis Partnering 2009-2014 provides understanding and access to the conjunctivitis partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 695
Optometry and Optical Dispensing in Australia - Industry Market Research Report
6/11/2014 | published by: IBISWorld
... dispensing spectacles and contact lenses. The main activity of optical dispensers is dispensing spectacles or contact lenses. Orthoptists diagnose and treat ocular muscle disorders. This report covers the scope, size, disposition and growth of the ...  |  read more...
USD 965
Ophthalmology: State Industry Market Evaluator
6/30/2014 | published by: BizMiner
... volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, establishments, small business, startups). startup activity rates ...  |  read more...
USD 699
Retinal Degeneration - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... therapeutic development for Retinal Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... Exudative) Macular Degeneration’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
USD 2,000
Global Retinal Vein Occlusion Market : 2014-2018
7/23/2014 | published by: TechNavio - Infiniti Research Ltd.
... AG, F. Hoffmann-La Roche Ltd., Novartis AG and Regeneron Pharmaceuticals Inc. Other prominent vendors in the market are: Alimera Sciences, Bristol-Myers Squibb, NicOx, Santen Pharmaceutical and Valeant Pharmaceuticals. Commenting on the report, an analyst from ...  |  read more...
USD 2,500
Market Highlights: Japan Age-related Macular Degeneration – 2014
5/1/2014 | published by: Fore Pharma
... forecast in Japan. The research includes Japan Age-related macular degeneration market size estimates for 2013, market share forecast for six years to 2019, Age-related macular degeneration drugs market share, Age-related macular degeneration drugs sales estimates, ...  |  read more...
USD 990
Market Highlights: Europe Age-related Macular Degeneration – 2014
5/1/2014 | published by: Fore Pharma
... for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) Age-related macular degeneration market size estimates for 2013, market share forecast for six years to 2019, Age-related macular ...  |  read more...
USD 2,800
Ophthalmic Drugs Market Forecast 2014-2024
6/16/2014 | published by: Visiongain
... you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 337-page report provides 198 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our ...  |  read more...
USD 3,004
Market Highlights: UK Cataract – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, cataract drugs market share, cataract drugs sales estimates, cataract drugs sales forecast, and cataract late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Dry Eye Syndrome: Clinical Trial Tracker
4/29/2014 | published by: Roots Analysis
... no cure for dry eye syndrome, but there are treatments to control its symptoms. The prevalence of dry eye syndrome primarily increases with age, and has an estimated incidence of 15% in persons over the ...  |  read more...
USD 799
Update: Age-Related Macular Degeneration Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... It covers emerging therapies for Age-Related Macular Degeneration in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 590
< prev 1    3  4  5  6  7  8  9  10